Form 4: NeuroOne Medical Technologies CEO David Rosa Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
David Rosa, CEO and President of NeuroOne Medical Technologies, disposed of 4,697 shares of common stock on June 30, 2024, to cover tax obligations.
Summary
- On June 30, 2024, David A Rosa, CEO and President of NeuroOne Medical Technologies Corp, disposed of 4,697 shares of common stock.
- The transaction was executed to cover tax obligations.
- Following the transaction, Rosa directly owns 1,155,661 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This allows investors to monitor the actions of key personnel and their potential impact on the company's stock.
Stakeholder Impact
- Shareholders may be interested in the insider's transactions as an indicator of management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 06/30/2024 | Date of transaction: David Rosa disposed of shares. |
| 07/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.